{"PubmedArticle": [{"MedlineCitation": {"InvestigatorList": [], "SpaceFlightMission": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "OtherID": [], "PMID": "9430423", "DateCompleted": {"Year": "1998", "Month": "03", "Day": "03"}, "DateRevised": {"Year": "2019", "Month": "06", "Day": "24"}, "Article": {"Language": ["eng"], "ELocationID": [], "ArticleDate": [], "Journal": {"ISSN": "0014-2999", "JournalIssue": {"Volume": "337", "Issue": "2-3", "PubDate": {"Year": "1997", "Month": "Oct", "Day": "22"}}, "Title": "European journal of pharmacology", "ISOAbbreviation": "Eur J Pharmacol"}, "ArticleTitle": "Angiotensin-converting enzyme inhibitors can potentiate ozone-induced airway hyperresponsiveness.", "Pagination": {"StartPage": "259", "EndPage": "265", "MedlinePgn": "259-65"}, "Abstract": {"AbstractText": ["We investigated the effects of single and chronic oral administration of angiotensin-converting enzyme inhibitors on ozone-induced airway hyperresponsiveness in guinea pigs. Ozone exposure (3 ppm for 2 h) significantly increased airway responsiveness in vehicle-treated animals and in animals with either single or chronic administration (8 days) of drugs. Single administration of imidapril, enalapril and captopril significantly potentiated ozone-induced airway hyperresponsiveness at a dose of 100, 50 and 50 mg/kg, respectively, although these doses did not influence airway responsiveness in normal guinea pigs, i.e., the magnitude of potentiation was captopril > enalapril > imidapril. In the study of chronic administration of the drugs, imidapril (10-100 mg/kg per day) had no influence on airway responsiveness in both normal and ozone-treated animals. In contrast, captopril and enalapril (10-100 mg/kg per day) dose-dependently potentiated ozone-induced airway hyperresponsiveness, with no influence on airway responsiveness in normal animals. That is, the magnitude was enalapril > captopril. These results indicate that angiotensin-converting enzyme inhibitors potentiate airway responsiveness in ozone-treated guinea pigs but not in normal guinea pigs and that imidapril is less potent than enalapril and captopril in potentiating ozone-induced airway hyperresponsiveness in guinea pigs."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Lead Optimization Research Laboratory, Tanabe Seiyaku Co., Ltd., Toda, Saitama, Japan. s-matsu@tanabe.co.jp"}], "Identifier": [], "LastName": "Matsubara", "ForeName": "S", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kikkawa", "ForeName": "H", "Initials": "H"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kaminuma", "ForeName": "O", "Initials": "O"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ikezawa", "ForeName": "K", "Initials": "K"}], "PublicationTypeList": ["Comparative Study", "Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Eur J Pharmacol", "NlmUniqueID": "1254354", "ISSNLinking": "0014-2999"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Angiotensin-Converting Enzyme Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Imidazoles"}, {"RegistryNumber": "0", "NameOfSubstance": "Imidazolidines"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "69PN84IO1A", "NameOfSubstance": "Enalapril"}, {"RegistryNumber": "9G64RSX1XD", "NameOfSubstance": "Captopril"}, {"RegistryNumber": "BW7H1TJS22", "NameOfSubstance": "imidapril"}], "MeshHeadingList": [{"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Angiotensin-Converting Enzyme Inhibitors"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemically induced", "physiopathology"], "DescriptorName": "Bronchial Hyperreactivity"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Captopril"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Enalapril"}, {"QualifierName": [], "DescriptorName": "Guinea Pigs"}, {"QualifierName": ["administration & dosage", "pharmacology"], "DescriptorName": "Imidazoles"}, {"QualifierName": [], "DescriptorName": "Imidazolidines"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["toxicity"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Respiratory Function Tests"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1998", "Month": "1", "Day": "16"}, {"Year": "1998", "Month": "1", "Day": "16", "Hour": "0", "Minute": "1"}, {"Year": "1998", "Month": "1", "Day": "16", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["9430423", "10.1016/s0014-2999(97)01316-2", "S0014-2999(97)01316-2"]}}], "PubmedBookArticle": []}